Kiniksa Pharmaceuticals, Ltd.
KNSA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $174,858 | $192,037 | $157,132 | $183,581 |
| Short-Term Investments | $177,244 | $115,745 | $111,208 | $60,046 |
| Receivables | $51,742 | $31,910 | $40,065 | $41,724 |
| Inventory | $41,396 | $48,181 | $22,069 | $26,364 |
| Other Curr. Assets | $30,290 | $32,438 | $25,433 | $20,084 |
| Total Curr. Assets | $475,530 | $420,311 | $355,907 | $331,799 |
| Property Plant & Equip (Net) | $11,728 | $11,380 | $11,059 | $11,038 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $15,500 | $15,750 | $16,000 | $16,250 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $201,287 | $205,514 | $208,158 | $211,151 |
| Other NC Assets | $8,288 | $8,195 | $8,202 | $10,315 |
| Total NC Assets | $236,803 | $240,839 | $243,419 | $248,754 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $712,333 | $661,150 | $599,326 | $580,553 |
| Liabilities | – | – | – | – |
| Payables | $6,150 | $8,956 | $1,982 | $2,039 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $31,811 | $0 | $0 |
| Other Curr. Liab. | $37,560 | -$628 | $25,891 | $33,123 |
| Total Curr. Liab. | $123,592 | $117,827 | $97,267 | $100,621 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $31,811 | $31,811 | $31,811 | $31,811 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $14,525 | $9,262 | $5,136 | $1,823 |
| Total NC Liab. | $53,358 | $48,316 | $44,570 | $41,496 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $9,718 | $9,765 | $9,915 | $9,855 |
| Total Liabilities | $176,950 | $166,143 | $141,837 | $142,117 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $21 | $21 | $20 | $20 |
| Retained Earnings | -$476,337 | -$494,772 | -$512,604 | -$521,143 |
| AOCI | -$155 | -$53 | -$165 | -$163 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $535,383 | $495,007 | $457,489 | $438,436 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $712,333 | $661,150 | $599,326 | $580,553 |
| Net Debt | -$174,858 | -$192,037 | -$157,132 | -$183,581 |